LEDDS Trademark

Trademark Overview


On Friday, July 29, 2016, a trademark application was filed for LEDDS with the United States Patent and Trademark Office. The USPTO has given the LEDDS trademark a serial number of 87121385. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 21, 2019. This trademark is owned by Sigmoid Pharma Limited. The LEDDS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

(based on intent to use and Section 44e) pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disorders; (based on intent to use) Pharmaceutical and veterinary preparations and substances for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disorders

(based on intent to use and Section 44e) Scientific and biological research relating to the research and development of pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals and based on liquid emulsion drug delivery systems; medical research relating to the diagnosis and treatment of disease involving the use of pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals and based on liquid emulsion drug delivery systems; (based on intent to use) Scientific and biological research relating to the research and development of pharmaceutical and veterinary preparations and substances; medical research relating to the diagnosis and treatment of disease; medical research on the efficacy of pharmaceutical and ve...
ledds

General Information


Serial Number87121385
Word MarkLEDDS
Filing DateFriday, July 29, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 21, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2017

Trademark Statements


Goods and Services(based on intent to use and Section 44e) pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disorders; (based on intent to use) Pharmaceutical and veterinary preparations and substances for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disorders
Goods and Services(based on intent to use and Section 44e) Scientific and biological research relating to the research and development of pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals and based on liquid emulsion drug delivery systems; medical research relating to the diagnosis and treatment of disease involving the use of pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals and based on liquid emulsion drug delivery systems; (based on intent to use) Scientific and biological research relating to the research and development of pharmaceutical and veterinary preparations and substances; medical research relating to the diagnosis and treatment of disease; medical research on the efficacy of pharmaceutical and veterinary preparations and substances; medical and scientific research, namely, conducting clinical trials involving pharmaceutical and veterinary preparations and substances

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 3, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 3, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSigmoid Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin 9
IE

Party NameSigmoid Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 9
IE

Trademark Events


Event DateEvent Description
Tuesday, January 22, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 21, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 5, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 3, 2018EXTENSION 1 GRANTED
Thursday, May 3, 2018EXTENSION 1 FILED
Thursday, May 3, 2018TEAS EXTENSION RECEIVED
Tuesday, December 19, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 11, 2017EXAMINER'S AMENDMENT ENTERED
Monday, September 11, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 11, 2017EXAMINERS AMENDMENT E-MAILED
Monday, September 11, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, August 10, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 10, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 10, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, May 8, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, May 8, 2017FINAL REFUSAL E-MAILED
Monday, May 8, 2017FINAL REFUSAL WRITTEN
Tuesday, April 4, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 4, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 30, 2017ASSIGNED TO LIE
Friday, March 17, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 16, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 15, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 15, 2016NON-FINAL ACTION E-MAILED
Tuesday, November 15, 2016NON-FINAL ACTION WRITTEN
Wednesday, November 9, 2016ASSIGNED TO EXAMINER
Wednesday, August 3, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 2, 2016NEW APPLICATION ENTERED IN TRAM